30 research outputs found
HLA Alleles Associated with Slow Progression to AIDS Truly Prefer to Present HIV-1 p24
Background: The mechanism behind the association between human leukocyte antigen (HLA) molecules and the rate of HIV-1
disease progression is still poorly understood. Recent data suggest that ‘‘protective’’ HLA molecules, i.e. those associated with
a low HIV-1 viral load and relatively slow disease progression, tend to present epitopes from the Gag capsid protein. Although
this suggests that preferential targeting of Gag delays disease progression, the apparent preference for Gag could also be
a side-effect of the relatively high immunogenicity of the protein. Methods and Findings: To separate cause and effect, we
predicted HIV-1 epitopes from the whole genome of HIV-1, and found that protective HLA alleles have a true preference for the
p24 Gag protein, while non-protective HLA alleles preferentially target HIV-1 Nef. In line with this, we found a significant
negative correlation between the predicted affinity of the best-binding p24 epitopes and the relative hazard of HIV-1 disease
progression for a large number of HLA molecules. When the epitopes targeted by protective HLA alleles were mapped to the
known p24 structure, we found that mutations in these epitopes are likely to disturb the p24 dimer structure, which is
expected to severely reduce the fitness of the virus. Conclusions: Our results suggest that the intrinsic preference of different
HLA molecules to present p24 peptides explains why some HLA molecules are more protective than others
Genomics meets HIV-1
Genomics is now a core element in the effort to develop a vaccine against HIV-1. Thanks to unprecedented progress in high-throughput genotyping and sequencing, in knowledge about genetic variation in humans, and in evolutionary genomics, it is finally possible to systematically search the genome for common genetic variants that influence the human response to HIV-1. The identification of such variants would help to determine which aspects of the response to the virus are the most promising targets for intervention. However, a key obstacle to progress remains the scarcity of appropriate human cohorts available for genomic research
Broad and Gag-Biased HIV-1 Epitope Repertoires Are Associated with Lower Viral Loads
Background: HLA class-I alleles differ in their ability to control HIV replication through cell-mediated immune responses. No consistent associations have been found between the breadth of Cytotoxic T Lymphocytes (CTL) responses and the control of HIV-1, and it is unknown whether the size or distribution of the viral proteome-wide epitope repertoire, i.e., the intrinsic ability to present fewer, more or specific viral epitopes, could affect clinical markers of disease progression. Methodology/Principal Findings: We used an epitope prediction model to identify all epitope motifs in a set of 302 HIV-1 full-length proteomes according to each individual's HLA (Human Leukocyte Antigen) genotype. The epitope repertoire, i.e., the number of predicted epitopes per HIV-1 proteome, varied considerably between HLA alleles and thus among individual proteomes. In a subgroup of 270 chronically infected individuals, we found that lower viral loads and higher CD4 counts were associated with a larger predicted epitope repertoire. Additionally, in Gag and Rev only, more epitopes were restricted by alleles associated with low viral loads than by alleles associated with higher viral loads. Conclusions/Significance: This comprehensive analysis puts forth the epitope repertoire as a mechanistic component of the multi-faceted HIV-specific CTL response. The favorable impact on markers of disease status of the propensity to present more HLA binding peptides and specific proteins gives impetus to vaccine design strategies that seek to elicit responses to a broad array of HIV-1 epitopes, and suggest a particular focus on Gag